No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Tobacco
KT&G Corporation, a diversified South Korean enterprise that operates alongside its subsidiaries, specializes in a broad array of industries. Its primary business involves the manufacturing and distribution of tobacco products and related materials. Beyond this, the company is a significant provider of health and wellness items, offering red ginseng, various red ginseng-based goods, and other health-focused foods. Its extensive product portfolio also features food and beverage items, along with cosmetic and beauty products. Further diversifying its operations, KT&G offers support services for leaf tobacco cultivation and maintains a presence in the pharmaceutical and medical sectors. This includes the development, production, and supply of pharmaceuticals, encompassing bio-pharmaceuticals, over-the-counter medicines, and a range of medical supplies and equipment. The corporation also holds investments in commercial ventures such as trading, real estate management, property leasing, and housing development. Additionally, it is involved in the development and ongoing management of hotels. Founded in 1987, the company originally operated under the name Korea Tobacco and Ginseng Corporation before officially changing to KT&G Corporation in December 2002. Its corporate headquarters are situated in Daejeon, South Korea.
www.ktng.comNo one on the platform currently holds 033780.KS.
No tracked institution reports a position in 033780.KS as of their last filing.
No one on the platform has traded 033780.KS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 10.0% | 10.3% | 12.3% | — | — | — |
| Rev. Growth % | 11.4% | 4.4% | ||||
| Profit Margin % | 16.6% | 17.6% | 20.4% | |||
| Free Cash Flow Margin % | -0.3% | 9.0% | 13.8% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $7.03T | +7.9% | $12798.48 | $11230.67–$14106.10 | — | 14 |
| 2027 | $7.44T | +5.9% | $13941.43 | $12260.32–$16579.67 | — | 15 |
| 2028 | $7.77T | +4.3% | $14756.62 | $14232.42–$15476.64 | — | 7 |
| 2029 | $7.50T | -3.4% | $0.00 | $0.00–$0.00 | — | 9 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 4 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-06 | $2771.63 | $3069.13 | +10.7% |
| 2026-05-07 | $2865.03 | $2799.38 | -2.3% |
| 2026-02-06 | $3964.44 | $2305.94 | -41.8% |
| 2025-11-06 | $3024.82 | $3024.82 | +0.0% |
| 2025-08-07 | $2765.36 | $1328.89 | -51.9% |
| 2025-05-07 | $2132.65 | $2132.65 | +0.0% |
| 2025-02-06 | $1930.11 | $3016.08 | +56.3% |
| 2024-11-07 | $2425.20 |
| $2108.26 |
| -13.1% |
| $107100.00 |
| +3.08% |
| $3.90T |
| — |
| 090430.KSAmorepacific Corporation | $144000.00 | -1.37% | $8.41T | — |
| 090435.KSAmorepacific Corporation | $45800.00 | +1.22% | $8.32T | — |
Source: Financial Modeling Prep · peers by sector/industry